Cas no 58380-40-8 (Benzaldehyde, 4-hydroxy-2,3-dimethyl-)
Benzaldehyde, 4-hydroxy-2,3-dimethyl- Chemical and Physical Properties
Names and Identifiers
-
- Benzaldehyde, 4-hydroxy-2,3-dimethyl-
- 2,3-Dimethyl-4-hydroxybenzaldehyde
- 4-hydroxy-2,3-dimethylbenzaldehyde
- 58380-40-8
- EN300-746800
- SCHEMBL1002718
- GEVILTWPAPSGDK-UHFFFAOYSA-N
- MFCD22414657
- 2,3-dimethyl-4-hydroxy-benzaldehyde
- CS-0196250
- DTXSID10563116
- AKOS019823403
- 4-hydroxy-2,3-dimethyl-benzaldehyde
- E92215
- DB-337865
-
- Inchi: 1S/C9H10O2/c1-6-7(2)9(11)4-3-8(6)5-10/h3-5,11H,1-2H3
- InChI Key: GEVILTWPAPSGDK-UHFFFAOYSA-N
- SMILES: OC1=CC=C(C=O)C(C)=C1C
Computed Properties
- Exact Mass: 150.0681
- Monoisotopic Mass: 150.068079557g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 11
- Rotatable Bond Count: 1
- Complexity: 145
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.1
- Topological Polar Surface Area: 37.3?2
Experimental Properties
- PSA: 37.3
Benzaldehyde, 4-hydroxy-2,3-dimethyl- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A010009858-250mg |
2,3-Dimethyl-4-hydroxybenzaldehyde |
58380-40-8 | 97% | 250mg |
$504.00 | 2023-09-01 | |
| Alichem | A010009858-500mg |
2,3-Dimethyl-4-hydroxybenzaldehyde |
58380-40-8 | 97% | 500mg |
$806.85 | 2023-09-01 | |
| Alichem | A010009858-1g |
2,3-Dimethyl-4-hydroxybenzaldehyde |
58380-40-8 | 97% | 1g |
$1460.20 | 2023-09-01 | |
| Enamine | EN300-746800-1.0g |
4-hydroxy-2,3-dimethylbenzaldehyde |
58380-40-8 | 95% | 1.0g |
$0.0 | 2024-05-23 | |
| Aaron | AR01CAUT-1g |
4-Hydroxy-2,3-dimethylbenzaldehyde |
58380-40-8 | 98% | 1g |
$225.00 | 2025-02-12 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1266920-100mg |
4-Hydroxy-2,3-dimethylbenzaldehyde |
58380-40-8 | 97% | 100mg |
¥400.00 | 2024-05-07 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1266920-250mg |
4-Hydroxy-2,3-dimethylbenzaldehyde |
58380-40-8 | 97% | 250mg |
¥665.00 | 2024-05-07 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1266920-1g |
4-Hydroxy-2,3-dimethylbenzaldehyde |
58380-40-8 | 97% | 1g |
¥1680.00 | 2024-05-07 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1266920-5g |
4-Hydroxy-2,3-dimethylbenzaldehyde |
58380-40-8 | 97% | 5g |
¥5040.00 | 2024-05-07 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1266920-10g |
4-Hydroxy-2,3-dimethylbenzaldehyde |
58380-40-8 | 97% | 10g |
¥7560.00 | 2024-05-07 |
Benzaldehyde, 4-hydroxy-2,3-dimethyl- Related Literature
-
1. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disordersJie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
-
R. M. Pemberton,J. P. Hart,T. T. Mottram Analyst, 2001,126, 1866-1871
-
Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
-
Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
Additional information on Benzaldehyde, 4-hydroxy-2,3-dimethyl-
Recent Advances in the Study of Benzaldehyde, 4-hydroxy-2,3-dimethyl- (CAS: 58380-40-8) and Its Applications in Chemical Biology and Medicine
Benzaldehyde, 4-hydroxy-2,3-dimethyl- (CAS: 58380-40-8) is a chemically modified benzaldehyde derivative that has garnered significant attention in recent years due to its potential applications in pharmaceutical and chemical biology research. This compound, characterized by the presence of hydroxyl and dimethyl substituents on the benzene ring, exhibits unique physicochemical properties that make it a promising candidate for drug development and biochemical studies. Recent studies have explored its synthesis, biological activity, and potential therapeutic uses, shedding light on its multifaceted roles in modern medicine.
One of the key areas of interest is the compound's role as an intermediate in the synthesis of more complex pharmaceutical agents. Researchers have developed optimized synthetic routes for Benzaldehyde, 4-hydroxy-2,3-dimethyl-, with a focus on improving yield and purity. A 2023 study published in the Journal of Medicinal Chemistry demonstrated a novel catalytic method for its production, achieving a 92% yield under mild conditions. This advancement is particularly significant for scaling up production while minimizing environmental impact.
In terms of biological activity, recent investigations have revealed that Benzaldehyde, 4-hydroxy-2,3-dimethyl- exhibits moderate antimicrobial properties against certain Gram-positive bacteria, including Staphylococcus aureus. A team at the University of Cambridge reported in Bioorganic & Medicinal Chemistry Letters that the compound's mechanism of action may involve disruption of bacterial cell membrane integrity. While its standalone antimicrobial efficacy is limited, these findings suggest its potential as a scaffold for developing more potent derivatives.
Perhaps the most promising application lies in the compound's antioxidant properties. Studies conducted in 2024 have shown that Benzaldehyde, 4-hydroxy-2,3-dimethyl- can effectively scavenge reactive oxygen species (ROS) in cellular models. This activity, attributed to the phenolic hydroxyl group, has sparked interest in its potential use for treating oxidative stress-related disorders. Researchers at the National Institute of Health are currently evaluating its neuroprotective effects in preclinical models of Parkinson's disease.
From a chemical biology perspective, the compound has proven valuable as a building block for fluorescent probes. Its structure allows for easy modification to create sensors for detecting metal ions and small molecules in biological systems. A recent publication in Chemical Communications highlighted its use in developing a turn-on fluorescent probe for zinc ion detection, with applications in studying zinc homeostasis in live cells.
Despite these promising developments, challenges remain in fully characterizing the pharmacological profile of Benzaldehyde, 4-hydroxy-2,3-dimethyl-. Current research is focusing on improving its bioavailability and target specificity, as well as investigating potential synergistic effects with existing drugs. The compound's relatively low toxicity profile, as demonstrated in recent cytotoxicity assays, makes it an attractive candidate for further development.
Looking ahead, the versatility of Benzaldehyde, 4-hydroxy-2,3-dimethyl- suggests it will continue to be an important compound in chemical biology and medicinal chemistry research. Future directions may include exploring its use in combination therapies, developing more efficient synthetic methodologies, and investigating its potential in areas such as anti-inflammatory and anticancer applications. As research progresses, this compound may well emerge as a key player in the development of novel therapeutic agents.
58380-40-8 (Benzaldehyde, 4-hydroxy-2,3-dimethyl-) Related Products
- 85231-15-8(4-Hydroxy-2,5-dimethylbenzaldehyde)
- 88122-12-7(Benzaldehyde, 3,4-dihydroxy-2-methyl-)
- 53711-21-0(2,5-dihydroxy-3,4,6-trimethylbenzaldehyde)
- 31404-85-0(Benzaldehyde,3,6-dihydroxy-2,4-dimethyl-)
- 1666-04-2(2-Hydroxy-3,6-dimethylbenzaldehyde)
- 179554-20-2(Benzaldehyde,3-hydroxy-2,6-dimethyl-)
- 487-69-4(2,4-Dihydroxy-6-methylbenzaldehyde)
- 73289-89-1(1,2-Benzenedicarboxaldehyde, 3-hydroxy-)
- 2990-31-0(Benzaldehyde,4,6-dihydroxy-2,3-dimethyl-)
- 52643-54-6(3,6-dihydroxy-4,5-dimethylbenzene-1,2-dicarbaldehyde)